Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02241941
Other study ID # Dapto-ICU-09
Secondary ID EK-1748
Status Withdrawn
Phase Phase 4
First received September 13, 2014
Last updated October 27, 2016
Start date September 2014
Est. completion date October 2016

Study information

Verified date October 2016
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority Switzerland: Swissmedic
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine single dose pharmacokinetics of daptomycin consecutively in 10 patients on three different time points after severe burn injury.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date October 2016
Est. primary completion date October 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Male or female of 18 years or older

- Second and/or third degree thermal injury

- Total body surface area burned = 15%

- Hospitalisation in the ICU for burn injured patients of the University Hospital Zürich

- Probability of ICU stay of >14 days

- Written informed consent by the patient or in patients unable to be informed or to sign according to section 4.4 of the study protocol

Exclusion Criteria:

- Evidence of renal failure (Creatinine clearance <30ml/min) or continuous renal replacement therapy such as continuous hemofiltration

- History of muscle disease or skeletal muscle disorder

- Creatine-phosphokinase (CPK) = 5 times the upper limit of normal (ULN)

- History of hypersensitivity to the drug

- Pregnancy

- Severe coagulation disorder

Study Design

Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Drug:
Daptomycin


Locations

Country Name City State
Switzerland University Hospital Zurich Zurich

Sponsors (1)

Lead Sponsor Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pharmacokinetic parameters of daptomycin up to 30 days Yes
Secondary Correlation of daptomycin plasma concentrations with tissue concentration up to 30 days Yes
Secondary degree of variability of daptomycin pk parameters in dependency of body surface area burned up to 30 days Yes
See also
  Status Clinical Trial Phase
Completed NCT02210208 - A Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients. N/A
Completed NCT05063409 - Transfusion Ratio of Fresh Frozen Plasma (FFP) to Packed Red Blood Cell (PRBC) During Burn Excision and Grafting N/A
Completed NCT03730688 - Non-invasive Limb Compartment Pressure Measurement N/A
Recruiting NCT04368117 - STAT: Standard Therapy Plus Active Therapy N/A
Terminated NCT01773083 - Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma Phase 3
Completed NCT02092701 - Effects of Cholecalciferol Supplementation on Bone Health and Muscle Strength in Adults During Post-burn Period N/A
Recruiting NCT06263296 - Smartphone Assisted Self-management Education for Adult Burn Patient at Aftercare N/A
Completed NCT02145130 - Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects Phase 1
Completed NCT01618630 - Amino Acid Supplementation in Recovery From Severe Burns N/A
Recruiting NCT05876442 - Efficacy of EPSW Plus HILT on Carpal Tunnel Syndrome Post Burn Injury N/A
Completed NCT04417439 - The Effect of Acute Phase Treatment Approaches on Creatine Kinase and the Musculoskeletal System in Different Types of Burns
Completed NCT02417818 - Cutaneous Microcirculation After Plasma Therapy N/A
Completed NCT02417805 - Cutaneous Microcirculation After Remote Ischemic Preconditioning N/A
Completed NCT02417779 - Cutaneous Microcirculation After Extracorporeal Shock Wave Therapy N/A
Completed NCT01404026 - Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Due to Burn Injury N/A
Completed NCT03204669 - Trace Element Repletion Following Severe Burn Injury N/A
Recruiting NCT04947449 - Potential Benefits of Laser Treatment on Skin Blood Flow and Sweating in Burn Survivors
Not yet recruiting NCT05532488 - Inulin in Burn-induced Insulin Resistance N/A
Recruiting NCT02189538 - Effect of n-3 PUFA From Fish in Enteral Nutrition of Major Burn Patients N/A
Completed NCT01795079 - Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Following Burn Injury N/A